Testing treatment before or after breast cancer surgery
Part of Cancer, Skin clinical trials.
This trial studies how different cancer treatments given before or after standard therapy affect breast cancer cells in the blood and bone marrow. It may help doctors better understand how treatments work throughout the body, not just where the tumor is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have recently been diagnosed with breast cancer stage II, III, or IV
- You are planning to receive treatment through the bloodstream (systemic therapy) before or after surgery; you can also be eligible if you already finished the “before” (neoadjuvant) treatment
- You are at least 18 years old
- If you can become pregnant and you are female, you are not currently pregnant
- You do not have hepatitis B, hepatitis C, or HIV
- You are willing and able to sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether a blood test that looks at tumor cells can help guide treatment for people with breast cancer. If you join, your care team will follow your responses over time to see if this “phenotype surveillance” approach is useful.
This trial tests whether giving radiation therapy before surgery helps people with locally advanced breast cancer that hasn't been removed with chemotherapy. It may offer a new option for those who cannot have surgery right away.
This trial looks at different drug combinations given before surgery to shrink breast tumors. The goal is to find which treatments work best for different types of breast cancer, such as triple-negative, HER2-positive, or hormone-receptor-positive. If you are a woman scheduled for neoadjuvant therapy (treatment before surgery) and have not had previous cancer treatment, this study may be for you.
This trial looks at tumor cells in the blood of women with breast cancer to understand them better. It may help doctors learn more about how the disease spreads.
This trial uses a special blood test to track cancer signals (called ctDNA) during and after treatment for early breast cancer. It aims to see whether monitoring these signals can help guide follow-up and treatment decisions.
This trial tests a treatment given before breast surgery to shrink breast cancer and improve outcomes based on your tumor type. Your eligibility depends on tumor size/stage, hormone and HER2 markers, and overall health checks.
Hear when a new Breast Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.